Periactin Alternatives Compared
| Periactin (cyproheptadine) | Ubrelvy (ubrogepant) | Nurtec ODT (rimegepant) |
|
|---|
| Periactin (cyproheptadine) | Ubrelvy (ubrogepant) | Nurtec ODT (rimegepant) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Anorexia, Allergic Reactions, Allergies, Allergic Rhinitis, Anorexia Nervosa, Cluster Headaches, Cushing's Syndrome, Failure to Thrive, Migraine, Pruritus, Sexual Dysfunction - SSRI... View more |
Prescription only
Ubrelvy is a prescription medicine that may be used to treat acute migraine attacks in adults and works by blocking the effects of a protein, called CGRP that is thought to play a role in migraine... View more |
Prescription only
Nurtec ODT may be placed onto or under the tongue to treat the symptoms of migraine in adults, and it may also be used to prevent episodic migraine when taken every second day. Nurtec ODT works by... View more |
Related suggestions |
|||||||||||||||
| More about (cyproheptadine) | More about Ubrelvy (ubrogepant) | More about Nurtec ODT (rimegepant) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Periactin has an average rating of 9.0 out of 10 from a total of 65 ratings on Drugs.com. 86% of reviewers reported a positive effect, while 5% reported a negative effect. |
Ubrelvy has an average rating of 6.3 out of 10 from a total of 256 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 37% reported a negative effect. |
Nurtec ODT has an average rating of 6.4 out of 10 from a total of 317 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 30% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Ubrelvy prices |
View all Nurtec ODT prices |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
16 hours |
7 hours |
11 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 326 drugs are known to interact with Periactin:
|
A total of 231 drugs are known to interact with Ubrelvy:
|
A total of 161 drugs are known to interact with Nurtec ODT:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
December 23, 2019 |
February 27, 2020 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.